SCHEMBL17876126

SCHEMBL17876126

CC1(C)Oc2cc(-c3cccc4c3oc3ccccc34)ccc2-c2cc(-c3ccc4oc5ccccc5c4c3)ccc2O1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.48
GGPS1 O95749 1/20 0.38
PRKDC P78527 4/20 0.37
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP2C19 P33261 2/20 0.35
AVPR1A P37288 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PGR P06401 1/20 0.33
PLA2G10 O15496 1/20 0.32
PLA2G2A P14555 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876137 1.00 ALOX5 (0.48) ALOX5GGPS1PRKDCHSP90AA1HSP90AB1
SCHEMBL17876191 0.95 ALOX5 (0.52) ALOX5GGPS1PRKDCHSP90AA1HSP90AB1
SCHEMBL17876127 0.94 ALOX5 (0.53) ALOX5GGPS1PRKDCPTGES2MEN1
SCHEMBL17876128 0.93 ALOX5 (0.48) ALOX5GGPS1PRKDCPTGES2MEN1
SCHEMBL17876145 0.93 ALOX5 (0.48) ALOX5GGPS1PRKDCPTGES2MEN1
SCHEMBL17876146 0.91 ALOX5 (0.48) ALOX5GGPS1PRKDCPTGES2MEN1
SCHEMBL17876129 0.91 ALOX5 (0.48) ALOX5GGPS1PRKDCPTGES2MEN1
SCHEMBL17876150 0.91 MAPT (0.40) ALOX5HSP90AA1HSP90AB1MEN1KMT2A
SCHEMBL17876143 0.90 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2MEN1
SCHEMBL17876157 0.90 ALOX5 (0.47) ALOX5GGPS1PRKDCPTGES2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ALOX5 3059/4885GGPS1 1622/4885PRKDC 4858/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALOX5 3059/4885GGPS1 1622/4885PRKDC 4858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.